Celldex (CLDX) Tops Q2 EPS by 1c

Celldex (NASDAQ: CLDX) reported Q2 EPS of ($0.85), $0.01 better than the analyst estimate of ($0.86). Revenue for the quarter came in at $730 thousand versus the consensus estimate of $1.01 million.

For earnings history and earnings-related data on Celldex (CLDX) click here.

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• RBC Capital on DXC Technology (DXC): 'Focus on Software and AI to Accelerate Growth'
• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO